• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login

    • Male Breast Cancer Companies

    ID: MRFR/Pharma/5043-HCR
    100 Pages
    Rahul Gotadki
    September 2025

    Male breast cancer is a rare condition, and companies involved in the management and treatment of this cancer type play a crucial role in providing solutions for diagnosis, treatment, and support. Pharmaceutical companies may develop and manufacture medications specifically tailored for the treatment of male breast cancer. This could include hormone therapies, chemotherapy agents, targeted therapies, and immunotherapies.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Male Breast Cancer Market Research Report – Forecast to 2032 Infographic
    Summary Table of Contents Segmentation Infographic

    Top Industry Leaders in the Male Breast Cancer Market

    Male Breast Cancer Market

     


    Latest Male Breast Cancer Companies Updates:


    Jan 2024


    AstraZeneca Initiated a Phase 2 clinical trial evaluating their PARP inhibitor, olaparib, in combination with trastuzumab for treating HER2-positive metastatic male breast cancer.Partnered with patient advocacy groups to raise awareness about male breast cancer and promote early detection efforts.


    Pfizer Submitted a regulatory application for their PD-L1 inhibitor, talazoparib, in combination with enzalutamide for treating castration-resistant male breast cancer with BRCA mutations.Collaborated with leading cancer centers to establish clinical research networks dedicated to investigating new therapies for male breast cancer.


    Novartis AG (Switzerland) Presented positive Phase 2 data demonstrating the potential of their CDK4/6 inhibitor, ribociclib, in combination with letrozole for treating advanced hormone receptor-positive male breast cancer.Launched educational initiatives for healthcare professionals to improve knowledge and early diagnosis of male breast cancer.


    Foundation Medicine,Developed and launched a comprehensive genomic profiling test for male breast cancer, helping identify actionable mutations and guide personalized treatment decisions.Partnered with academic institutions to study the genetic landscape of male breast cancer and identify potential therapeutic targets.


    Male Breast Cancer Coalition Launched a nationwide awareness campaign promoting self-examination and encouraging men to discuss potential breast cancer symptoms with their doctors.Advocated for increased funding for male breast cancer research and improved access to clinical trials for male patients.


    List of Male Breast Cancer Key companies in the market:



    • Achieve Life Sciences, Inc.

    • Pfizer Inc.

    • Eli Lilly And Company

    • Bristol-Myers Squibb Company

    • F. Hoffman-La Roche Ltd.

    • Sanofi

    • Novartis AG

    • BioNumerik Pharmaceuticals Inc.

    • GlaxoSmithKline Plc.

    • Teva Pharmaceutical Industries Ltd.

    • Sun Pharmaceutical Industries Ltd.

    • AstraZeneca

    • Accord Healthcare

    • Bayer AG